Marksans Pharma arm gets marketing authorization for muscle relaxant tablets in UK

Mumbai: Marksans Pharma Limited's wholly owned subsidiary in the UK, Relonchem Limited receives marketing authorization for the product Baclofen 10 mg Tablets from UK MHRA.

This medication helps relax specific muscles in the body, relieving spasms, cramps, and tightness associated with multiple sclerosis or spinal injuries.

Medical Dialogues team had earlier reported that Relonchem had received Marketing Authorization for the product Ibuprofen and Paracetamol200 mg/500 mg Film-coated Tablets (Bell's Healthcare Dual Action Pain Relief 200 mg/500 mg Film-coated Tablets).

Read also: Marksans Pharma UK arm gets marketing nod for Ibuprofen, Paracetamol Film-coated Tablets

Marksans Pharma Limited is headquartered at Mumbai, India is engaged in Research, Manufacturing & Marketing of generic pharmaceutical formulation in the global markets. The company's manufacturing facilities located in India, USA and UK are approved by several leading regulatory agencies including USFDA, UKMHRA and Australian TGA. The company's product portfolio spreads over major therapeutic segments of CVS, CNS, Anti-diabetic, Pain Management, Gastroenterological and Antiallergies. The company is marketing these products globally.